Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	101.03B -2.4%
Revenue (ttm)	89.16B +2.1%
Net Income	8.45B -14.9%
EPS	191.79 -14.9%
Shares Out	44.08M
PE Ratio	11.95
Forward PE	9.72
Dividend	50.00 (2.18%)
Ex-Dividend Date	Mar 30, 2026

Volume	150,000
Open	2,270.00
Previous Close	2,270.00
Day's Range	2,267.00 - 2,292.00
52-Week Range	1,878.00 - 2,434.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,746
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In fiscal year 2026, Zeria Pharmaceutical's revenue was 89.16 billion, an increase of 2.12% compared to the previous year's 87.31 billion. Earnings were 8.45 billion, a decrease of -14.92%.